Veterinary News and Research

RSS

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy.

17 Oct 2014

Scientific insights into flu viruses must not give way to complacency, say researchers

As our ability to assess the pandemic risk from strains of influenza virus increases with the latest scientific developments, we must not allow ourselves to become complacent that the most substantial threats have been identified, argue an international consortium of scientists.

17 Oct 2014

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies.

16 Oct 2014

New mutations in cat genome identified as causes of human eye diseases

Researchers from the University of Missouri and the 99 Lives Cat Genome Sequencing Initiative today announced groundbreaking discoveries of novel mutations in the cat genome found to correlate to two human eye diseases, retinitis pigmentosa and Leber's Congenital Amaurosis.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Blocking STAT3 in immune system cells increases anti-tumour immunity

The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumour immunity. Anti-STAT3 therapy may thus be highly promising.

13 Oct 2014

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

New Ebola research demonstrates that quick and forceful implementation of control interventions are necessary to control outbreaks and avoid far worse scenarios.

10 Oct 2014

Researchers explore risks associated with consumption of bat bushmeat

Ebola, as with many emerging infections, is likely to have arisen due to man's interaction with wild animals – most likely the practice of hunting and eating wild meat known as 'bushmeat'. A team of researchers led by the University of Cambridge and the Zoological Society of London has surveyed almost six hundred people across southern Ghana to find out what drives consumption of bat bushmeat – and how people perceive the risks associated with the practice.

10 Oct 2014

Kansas State professor aims to develop vaccines to protect against tick-borne diseases

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

9 Oct 2014

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.

8 Oct 2014

UW-Madison's Yoshihiro Kawaoka recognized for efforts to prevent pandemic influenza

The University of Wisconsin-Madison's Yoshihiro Kawaoka has been recognized as a 2014 Popular Mechanics Breakthrough Award recipient for his efforts to understand and prevent pandemic influenza.

8 Oct 2014

Gut microbe in patients may tip doctors about SCID

Many people recognize "the bubble boy" as an unusual character from a "Seinfeld" episode or a John Travolta movie.

30 Sep 2014

Colorado cancer researchers launch feasibility study to build nation's first carbon-ion radiotherapy facility

Colorado cancer researchers and medical doctors on Wednesday announced they are launching a $200,000 feasibility study as a key step to building the nation's first carbon-ion radiotherapy research and treatment facility in Aurora, where they and colleagues hope to investigate and provide to patients leading-edge radiation therapy that is effective against the deadliest cancers and now is available only in Europe and Japan.

25 Sep 2014

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Cancer, while always dangerous, truly becomes life-threatening when cancer cells begin to spread to different areas throughout the body.

25 Sep 2014

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

24 Sep 2014

Neogen's first quarter net income increases 13%

Neogen Corporation announced today that net income for the first quarter of its 2015 fiscal year, which ended Aug. 31, was $8,883,000 — a 13% increase compared to net income of $7,839,000 in the first quarter of last year.

22 Sep 2014

MU researchers make new breakthrough in spinal muscular atrophy drug

According to recent studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that causes muscles to weaken over time.

16 Sep 2014

Scientists crack genetic code of liver fluke parasite

Singapore-An international team of scientists from Singapore, Thailand, China and Australia has cracked the genetic code of the liver fluke parasite, Opisthorchis viverrini, using a unique DNA analysis technique developed at A*STAR's Genome Institute of Singapore (GIS).

11 Sep 2014

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

The European Commission granted marketing authorisation for Eli Lilly and Company and Boehringer Ingelheim's insulin glargine product, indicated to treat diabetes in adults, adolescents and children aged 2 years and above.

10 Sep 2014

Novel virus could be source of severe respiratory disease in ball pythons

Researchers have identified a novel virus that could be the source of a severe, sometimes fatal respiratory disease that has been observed in captive ball pythons since the 1990s. The work is published this week in mBio-, the online open-access journal of the American Society for Microbiology.

9 Sep 2014